Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2009
12/30/2009WO2009156584A1 Assessing risk of metastases and/or ddfs of patients with neoplasms, screening of patients responding to cancer therapy and such therapy
12/30/2009WO2009156541A1 Fluorescent sensor and use thereof for detection of cyclin-dependent kinase inhibitors and/or for detection of cyclins
12/30/2009WO2009156475A1 Method for the specific detection of map antibodies
12/30/2009WO2009156453A1 Method for evaluating the amount of methane produced by a dairy ruminant and method for decreasing and controlling this amount
12/30/2009WO2009156446A1 Composite structure comprising a nanoparticle and a dendritic macromolecule having saccharide units
12/30/2009WO2009156422A1 Novel mitochondrial dye
12/30/2009WO2009156413A1 Established human brown adipocyte line and method for differentiation from an hmads cell line
12/30/2009WO2009156395A1 Method for the early detection of a map infection
12/30/2009WO2009156371A1 Genes for modulating coffee maturation and methods for their use
12/30/2009WO2009156343A2 Hand-held analysis appliance for analysing a body fluid, and method for controlling said appliance
12/30/2009WO2009156179A1 Her3 as a determinant for the prognosis of melanoma
12/30/2009WO2009156178A1 Flow-cytometric method for the determination of the total leukocyte number and thrombocyte number and for the leukocyte differentiation in avian blood samples
12/30/2009WO2009156172A1 System for the determination of molecules altering the function of interferon, method therefor and compounds altering interferon activity
12/30/2009WO2009156137A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
12/30/2009WO2009156075A1 Method for the determination of trichinella infections and diagnostic composition for such methods
12/30/2009WO2009155783A1 A portal detection apparatus for passer security
12/30/2009WO2009155774A1 Security inspection system for personnel
12/30/2009WO2009155709A1 Bridged secondary amines and use thereof as iap bir domain binding compounds
12/30/2009WO2009155669A1 Method of treatment of vascular complications
12/30/2009WO2009155637A1 Protocols for treating and preventing obesity and complications arising therefrom
12/30/2009WO2009137713A3 Particle-based electrostatic sensing and detection
12/30/2009WO2009137586A3 Use of inhaled substances for diagnosis of early lung cancer
12/30/2009WO2009137543A3 Methods for breast cancer screening and treatment
12/30/2009WO2009137475A3 Compositions and methods for diagnosing late-onset alzheimer's disease
12/30/2009WO2009137244A9 Cartridge and method for sample analysis
12/30/2009WO2009137211A3 Fibrous assemblies for antibody presentation, and multiplexed antigenic analysis using same
12/30/2009WO2009134327A3 Methods and reagents to increase the sensitivity of enzyme metallographic detection
12/30/2009WO2009132081A3 Monoclonal antibody-based targeting of folate receptors
12/30/2009WO2009126966A3 Genetic markers indicating biological response to a plk1 kinase inhibitor
12/30/2009WO2009126698A3 Regulation of fatty acid transporters
12/30/2009WO2009126652A3 Glycan based array and uses thereof
12/30/2009WO2009123762A3 Method of screening single cells for the production of biologically active agents
12/30/2009WO2009120800A3 Prognostic panel for urinary bladder cancer
12/30/2009WO2009120341A3 Biomarkers for predicting response to immunosuppressive therapy
12/30/2009WO2009120313A3 Identification of human t2r receptors that respond to bitter ligands in soy and related assays for identifying bitter taste modulators
12/30/2009WO2009117368A3 Relative blood hematocrit level using an automated integrated fluid delivery and blood access device
12/30/2009WO2009117032A3 High throughput methods for analysis of contamination in environmental samples
12/30/2009WO2009111476A3 Assay for systematic lupus erthematosus
12/30/2009WO2009111471A3 Collagen-derived peptide as biomarker, therapeutic agent and target
12/30/2009WO2009108837A3 Serotonin transporter gene and treatment of alcoholism
12/30/2009WO2009108340A3 Leptin agonist and methods of use
12/30/2009WO2009108168A3 Gold nanoparticle glycoconjugates for generating igg specific for the carbohydrate
12/30/2009WO2009103081A3 Glucocorticoid receptor polymorphisms
12/30/2009WO2009100445A3 Compositions and methods which modulate g-protein signaling for the treatment of asthma
12/30/2009WO2009098191A3 Method to produce hyperpolarised amino acids and aminosulphonic acids
12/30/2009WO2009097587A3 Nanoscale bound bilayers, methods of use and production
12/30/2009WO2009097262A3 Chitotriosidase and methods of use thereof
12/30/2009WO2009095876A3 Detection and automatic correction for deposition in a tubular using multi-energy gamma-ray measurements
12/30/2009WO2009088983A3 Insulin pump with insulin therapy coaching
12/30/2009WO2009088975A3 Methods and compositions for non-covalently enhanced receptor binding
12/30/2009WO2009086189A3 Use of activating transcription factor-2 (atf2) for detecting skin cancer
12/30/2009WO2009085221A3 Detection of methicillin-resistant staphylococcus aureus
12/30/2009WO2009079456A3 Gender-specific separation of sperm cells and embryos
12/30/2009WO2009079156A3 Detection devices and methods
12/30/2009WO2009076235A4 Cell assay kit and method
12/30/2009WO2009075773A3 Identification of toxin ligands
12/30/2009WO2009072009A8 Method for determining the toxicity of a toxin or a toxoid
12/30/2009WO2009069008A3 Composition and method for diagnosing fungal disease
12/30/2009WO2009069007A3 Composition and method for prediction of complicated disease course in crohn's disease
12/30/2009WO2009065054A3 Antibodies specific for the protofibril form of beta-amyloid protein
12/30/2009WO2009064973A4 Diagnostic kits and methods for scd or sca therapy selection
12/30/2009WO2009064897A3 Detection of nucleic acid sequence variations in circulating nucleic acid in bovine spongiform encephalopathy
12/30/2009WO2009063315A3 Method for determining the heating value and the relative density of a hydrocarbon fuel and apparatus for the same
12/30/2009WO2009062166A3 Dna microarray based identification and mapping of balanced translocation breakpoints
12/30/2009WO2009061847A3 Methods for diagnosing and treating pelvic pain disorders via beta-catenin
12/30/2009WO2009061799A3 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
12/30/2009WO2009061640A3 Hepatitis b virus (hbv) specific oligonucleotide sequences
12/30/2009WO2009059327A3 Compositions and methods comprising biomarkers of sperm quality, semen quality and fertility
12/30/2009WO2009059014A3 Flow cell and system for detection of target in aqueous environment using arrayed imaging reflectometry
12/30/2009WO2009052417A3 Breast cancer profiles and methods of use thereof
12/30/2009WO2009049166A3 Genomic landscapes of human breast and colorectal cancers
12/30/2009WO2009045443A3 Methods and compositions related to synergistic responses to oncogenic mutations
12/30/2009WO2009042237A3 Methods and compositions for modulating bcl-2 family polypeptides
12/30/2009WO2009039192A3 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
12/30/2009WO2009019600A3 Modulation of endogenous ampk levels for the treatment of obesity
12/30/2009WO2009016488A3 Compositions comprising tetracyclic antidepressants for treatment of cancer and related methods
12/30/2009WO2009016486A3 Use of nmda receptor antagonists for treatment of urologic tumors
12/30/2009WO2009014605A3 Methods and systems relating to mitochondrial dna phenotypes
12/30/2009WO2009002451A3 Adamts4 as a blood biomarker and therapeutic target for chronis renal failure
12/30/2009WO2008157403A3 Method and apparatus for metal nanoparticle electrocatalytic amplification
12/30/2009WO2008140639A3 Biomarkers and assays for alzheimer's disease
12/30/2009WO2008137865A3 Detecting isomers using differential derivatization mass spectrometry
12/30/2009WO2008134718A3 Protein binding determination and manipulation
12/30/2009WO2008122002A3 Organism identification panel
12/30/2009WO2008094621A3 Methods for allergen detection
12/30/2009WO2008088771A3 Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens
12/30/2009WO2008082498A8 Process and apparatus for online detection of surface irregularity in threadlines
12/30/2009WO2007137257A3 System and method for preparing samples
12/30/2009WO2005040229A3 Ldl receptor class a and egf domain monomers and multimers
12/30/2009EP2138850A1 Liquid feeding apparatus and liquid feeding control method
12/30/2009EP2138848A1 Method for the diagnosis and/or prognosis of cancer of the bladder
12/30/2009EP2138847A1 Method for determining an analyte in a bodily fluid
12/30/2009EP2138846A1 Analyte test strip for accepting diverse sample volumes
12/30/2009EP2138845A1 Method of manufacturing analyte test strip for accepting diverse sample volumes.
12/30/2009EP2138844A1 Method for testing the response of cells to exposures with therapeutics
12/30/2009EP2138843A1 Method for determining calibration information of electrochemical sensors
12/30/2009EP2138842A1 Analysis handheld device for investigating a bodily fluid and control method for same
12/30/2009EP2138841A2 System and method for measuring an analyte in a sample
12/30/2009EP2138840A1 A method for evaluating the surface activity of test preparations
12/30/2009EP2138835A1 Method and system for suppressing bindings on magnetic particles
1 ... 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 ... 3937